Market
What will be the outcome of H.R.3391 in the Senate by December 31, 2025?
2
Republican•House•Senate•Democrat•Chuck Schumer•Republicans•Democrats•Hakeem Jeffries•Elon Musk•Senate Democrats
Resolution / Starting Odds
Passed and signed into law • 25%
Passed but not signed into law • 25%
Not passed • 25%
No vote held • 25%
Official records from the U.S. Senate or a reputable news source
Story
Senate Democrats, Led by Chuck Schumer, Stall H.R.3391 Pediatric Cancer Research Funding Passed by Republican-led House
Dec 20, 2024, 06:15 PM
A $190 million funding bill for pediatric cancer research, known as H.R.3391 - the Gabriella Miller Kids First Research Act 2.0, was passed by the Republican-led House on March 5, 2024, with a vote of 384-4. The bill was received in the Senate on March 6, 2024, but has been stalled in the Democrat-controlled Senate. Senate Majority Leader Chuck Schumer has not brought the bill to a vote, leading to accusations from Republicans that Democrats are using it as a bargaining chip. Democrats, including House Minority Leader Hakeem Jeffries, have criticized Republicans for cutting the funding from a recent continuing resolution (CR), attributing the decision to influence from Elon Musk. However, the bipartisan standalone bill for pediatric cancer research has been held up in the Senate since its passage in the House, with no action taken by Senate Democrats.
View original story
Similar markets
Fail • 25%
Pass • 25%
Not Considered • 25%
Amended and Passed • 25%
Not voted on • 25%
Passes with majority • 25%
Passes with tie-breaking vote • 25%
Fails • 25%
Passes with amendments • 25%
Fails to pass • 25%
Not voted on by deadline • 25%
Passes without amendments • 25%
Passes with majority • 33%
Fails to pass • 33%
Tied vote • 34%
Rejected • 25%
Passed • 25%
No Action • 25%
Amended • 25%
Passed with amendments • 25%
Passed without amendments • 25%
Rejected • 25%
No vote by December 31, 2025 • 25%
Postponed • 34%
Fails • 33%
Passes • 33%
